Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
Baxter
Cipla
Queensland Health
Federal Trade Commission

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 9,956,192

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,956,192
Title:Selective histone deactylase 6 inhibitors
Abstract: Disclosed are selective histone deactylase inhibitors (HDACi) that having Formula (I). Methods of making and using these inhibitors for the treatment of cancer, in particular melanoma are also disclosed. ##STR00001##
Inventor(s): Sotomayor; Eduardo M. (Tampa, FL), Bergman; Joel (Chicago, IL), Kozikowski; Alan (Chicago, IL), Woan; Karrune Veeraprasert (Gainesville, FL), Villagra; Alejandro V. (Tampa, FL)
Assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc. (Tampa, FL) Board of Trustees of The University of Illinois (Urbana, IL)
Application Number:15/231,187
Patent Claims:see list of patent claims

Details for Patent 9,956,192

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bristol Myers Squibb YERVOY ipilimumab INJECTABLE; INJECTION 125377 001 2011-03-25   Try a Free Trial 2038-10-17 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKinsey
Fuji
Teva
Citi
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.